Academic Journal
Effect of (-)-epicatechin on the modulation of progression markers of chronic renal damage in a 5/6 nephrectomy experimental model
| Title: | Effect of (-)-epicatechin on the modulation of progression markers of chronic renal damage in a 5/6 nephrectomy experimental model |
|---|---|
| Authors: | Jorge Montes-Rivera, Mónica Arellano-Mendoza, Nayelli Nájera, Leonardo Del Valle-Mondragón, Francisco Villarreal, Ivan Rubio-Gayosso, Javier Perez-Duran, Eduardo Meaney, Guillermo Ceballos |
| Source: | Heliyon, Vol 5, Iss 4, Pp e01512- (2019) |
| Publisher Information: | Elsevier, 2019. |
| Publication Year: | 2019 |
| Collection: | LCC:Science (General) LCC:Social sciences (General) |
| Subject Terms: | Cell biology, Pathology, Science (General), Q1-390, Social sciences (General), H1-99 |
| More Details: | Aims: To evaluate the effects of (-)-epicatechin (Epi) in the progression of kidney damage. Material and methods: We assessed the effects of Epi [0.01–20 mg/kg of body weight/day] during 14 days, in a 5/6 nephrectomy model in mice. Key findings: Nephrectomy-induced systolic arterial hypertension was significantly reduced in a dose dependent manner with Epi treatment. Increased serum creatinine and urea were reduced almost to normal values. The concentration of tetrahydrobiopterin (BH4), used as subrogate of endothelial dysfunction, decreased in nephrectomyzed animals, Epi treatment increased BH4 levels almost reaching normal values. The expression of angiotensin II receptor (AT1-R) and NADPH oxidase-4 (NOX-4) and 3-nitrotyrosine levels increased with nephrectomy and were reduced with Epi treatment. Renal tissue morphology in the remaining tissue was conserved with Epi treatment in a dose dependent manner. Significance.: Chronic kidney disease (CKD) is an independent cardiovascular risk factor associated with a mortality rate 10 to 20 times higher than that of the general population. High blood pressure, endothelial dysfunction and oxidative stress are important factors determining kidney damage progression. Findings of this study indicate that Epi is able to counteract the deleterious effects of subtotal nephrectomy and the structural and functional changes in the remnant kidney tissue, decreasing the progression of CKD. These results warrant the possibility of implement clinical trials to limit the progression of CKD in humans. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2405-8440 |
| Relation: | http://www.sciencedirect.com/science/article/pii/S2405844019322881; https://doaj.org/toc/2405-8440 |
| DOI: | 10.1016/j.heliyon.2019.e01512 |
| Access URL: | https://doaj.org/article/3b26b82955da4a2590cb594f5b7de7f4 |
| Accession Number: | edsdoj.3b26b82955da4a2590cb594f5b7de7f4 |
| Database: | Directory of Open Access Journals |
| ISSN: | 24058440 |
|---|---|
| DOI: | 10.1016/j.heliyon.2019.e01512 |
| Published in: | Heliyon |
| Language: | English |